Cite
Tourkina E, Bonner M, Oates J, et al. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair. 2011;4(1):15doi: 10.1186/1755-1536-4-15.
Tourkina, E., Bonner, M., Oates, J., Hofbauer, A., Richard, M., Znoyko, S., Visconti, R. P., Zhang, J., Hatfield, C. M., Silver, R. M., & Hoffman, S. (2011). Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis & tissue repair, 4(1), 15. https://doi.org/10.1186/1755-1536-4-15
Tourkina, Elena, et al. "Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide." Fibrogenesis & tissue repair vol. 4,1 (2011): 15. doi: https://doi.org/10.1186/1755-1536-4-15
Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, Znoyko S, Visconti RP, Zhang J, Hatfield CM, Silver RM, Hoffman S. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair. 2011 Jul 01;4(1):15. doi: 10.1186/1755-1536-4-15. PMID: 21722364; PMCID: PMC3155832.
Copy
Download .nbib